tirzepatide and vision issues GLP-1 Medications Your Vision: What You Should Know RACGP - Semaglutide links to

Peak pain occurred at 72 hours post-injection

The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis (Bays et al., NEJM 2025) reported 28.7% mean weight loss at 68 weeks at the 12 mg dose, plus a 75.8% reduction in WOMAC knee pain scores

Sounds helpful, right

We chose drugs that targeted key immunomodulatory pathways relevant to the pathogenesis of TB meningitis (aspirin, montelukast, bestatin, thalidomide, pomalidomide, navitoclax) 19,20,22,23,24,25 , showing promise in pulmonary TB (imatinib, roflumilast) 26,27,28 , or those being developed to target neuroinflammation for non-infectious indications (dabrafenib, palacaparib, semaglutide) 29,30,31